Difference in Pain, Quality of Life Following Vaginal Hysterectomy With Vaginal Reconstruction Versus Robotic Colpopexy?

September 7, 2016 updated by: TriHealth Inc.

Is There a Difference in Pain and Quality of Life Following Vaginal Hysterectomy With Vaginal Reconstruction Compared to Robotic Colpopexy? A Prospective Cohort Study

The purpose of this study is to to determine if there is a difference in patient related outcomes of pain and quality of life following vaginal hysterectomy with vaginal prolapse repair compared to robotic-assisted repair.

We hypothesize that pain and quality of life following robotic-assisted repair will be similar to that following vaginal reconstruction, when performed in conjunction with vaginal hysterectomy.

Study Overview

Status

Completed

Detailed Description

Since the introduction of the DaVinci robotic system (Intuitive Surgical, Sunnyvale, CA), there has been considerable debate regarding its use, cost-effectiveness, and subsequent impact on patient care. While some studies have examined surgical outcomes and analyzed costs of this technique compared to open, laparoscopic, and vaginal approaches, it remains unclear whether one route is superior.

Indeed, data evaluating robotic-assisted and laparoscopic approaches to hysterectomy have shown similar patient results, but some reports note higher costs and longer operating times with robotics. Others suggest contrary information, with comparable surgical time, reduced blood loss, shorter hospital stay, and lower rate of conversion to laparotomy using robotic-assisted hysterectomy compared to laparoscopic or abdominal. Research contrasting robot-assisted laparoscopic myomectomy with abdominal myomectomy posit greater cost associated with the robotic procedure, but enhanced benefit of decreased blood loss, complication rates, and length of stay.

However, these issues have not been explored in urogynecologic patients. A single study comparing robotic versus vaginal urogynecologic procedures in elderly women showed robotic surgery to be associated with fewer postoperative complications than the vaginal route. Nevertheless the procedures were not always performed in conjunction with hysterectomy, and the analysis was retrospective.

In our practice, vaginal hysterectomy is the preferred method when correcting uterovaginal prolapse. We then address the reconstruction either vaginally or robotically. Vaginal repairs are comprised of the following: a vaginal vault suspension using the uterosacral ligaments, enterocele repair, anterior repair, and posterior/rectocele repair. The robotic procedure performed is a robotic sacral colpopexy using lightweight, polypropylene mesh, as well as a posterior/rectocele repair transvaginally. Both of these techniques are well-researched, effective approaches to addressing prolapse in a durable way. However, it is not clear whether one is superior in patient-related quality of life outcomes. We seek to compare patient quality of life by assessing differences in subjective impressions of pain following these procedures

Study Type

Observational

Enrollment (Actual)

78

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45220
        • TriHealth Good Samaritan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients who have been scheduled for a vaginal hysterectomy with either vaginal or robot-assisted prolapse repairs with Cincinnati Urogynecology Associates will be approached for participation in the study.

Eligible subjects are patients of Cincinnati Urogynecology Associates, aged 18-90, planning to undergo a vaginal hysterectomy with robotic or vaginal reconstructive surgery for pelvic organ prolapse, as well as a posterior/rectocele repair, with or without a suburethral sling or ovarian removal. All subjects will undergo general anesthesia. Eligible subjects must be able to speak and read English, and be able to understand the informed consent statement.

Description

Inclusion Criteria:

  • patients of Cincinnati Urogynecology Associates
  • aged 18-90
  • planning to undergo a vaginal hysterectomy with robotic or vaginal reconstructive surgery for pelvic organ prolapse as well as a posterior/rectocele repair, with or without a suburethral sling or ovarian removal.
  • undergoing general anesthesia
  • able to speak and read English
  • able to understand the informed consent statement

Exclusion Criteria:

  • scheduled for repairs not involving a hysterectomy
  • use of mesh in the vaginal prolapse repair
  • obliterative procedures to the vagina
  • concurrent removal of a suburethral sling
  • anterior, posterior or apical vaginal mesh kit at the time of their surgery
  • performance of vaginal 'relaxing incisions' at the time of vaginal surgery
  • concurrent anal incontinence repair such as a sphincteroplasty
  • presence of uterine, cervical or ovarian malignancy
  • use of regional anesthesia for their surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Robotic-assisted prolapse repair
Subjects already scheduled for robotic-assisted prolapse repair in conjunction with vaginal hysterectomy
Vaginal prolapse repair
Subjects already scheduled for vaginal prolapse repair in conjunction with vaginal hysterectomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective assessment of pain on the morning of post-operative day 1
Time Frame: One day (the day after surgery)
Subjective assessment of pain on the morning of post-operative day 1, prior to discharge, on a 150 mm visual analog scale (Surgical Pain Scale) The average pain that day at rest and the WORST pain that day will be the primary outcomes of pain.
One day (the day after surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective assessment of pain at 2 week postoperative visit and 6 week postoperative visit
Time Frame: 2 week postoperative visit
Subjective assessment of pain at 2 week postoperative visit and 6 week postoperative visit on a 150 mm visual analog scale (Surgical Pain Scale).
2 week postoperative visit
Subjective assessment of pain at 2 week postoperative visit and 6 week postoperative visit
Time Frame: 6 week postoperative visit
Subjective assessment of pain at 2 week postoperative visit and 6 week postoperative visit on a 150 mm visual analog scale (Surgical Pain Scale).
6 week postoperative visit
Quality of life at baseline, 2 week postoperative, and 6 week postoperative visit
Time Frame: 1 day (Baseline, day of surgery)
General Health Survey- Short Form 12 looking at quality of life at baseline, 2 week postoperative, and 6 week postoperative visit.
1 day (Baseline, day of surgery)
Quality of life at baseline, 2 week postoperative, and 6 week postoperative visit.
Time Frame: 2 week postoperative visit
General Health Survey- Short Form 12 looking at quality of life at baseline, 2 week postoperative, and 6 week postoperative visit.
2 week postoperative visit
Quality of life at baseline, 2 week postoperative, and 6 week postoperative visit.
Time Frame: 6 week postoperative visit
General Health Survey- Short Form 12 looking at quality of life at baseline, 2 week postoperative, and 6 week postoperative visit.
6 week postoperative visit
Intraoperative time
Time Frame: Intraoperative
Length of surgery
Intraoperative
Estimated blood loss
Time Frame: Intraoperative
Estimated blood loss during surgery.
Intraoperative
Surgical complications
Time Frame: Intraoperative
Complications that occur during surgery.
Intraoperative
Voiding trial results
Time Frame: 1 day (day after surgery)
Results of voiding trial which assesses postoperative bladder function.
1 day (day after surgery)
Hospital length of stay
Time Frame: 1-2 days
Length of stay in the hospital for surgery and postoperative care.
1-2 days
POP-Q preoperatively and postoperatively
Time Frame: several weeks
Comparison measurement of prolapse using pelvic organ prolapse quantification scale (POP-Q) preoperatively and postoperatively.
several weeks
Hemoglobin/hematocrit measurement
Time Frame: 1 day (postoperative day 1)
Measurement of blood count (hemoglobin/hematocrit levels) on postoperative day 1.
1 day (postoperative day 1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Lauren B. Westermann, DO, TriHealth Good Samaritan Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

January 28, 2014

First Submitted That Met QC Criteria

January 28, 2014

First Posted (Estimate)

January 30, 2014

Study Record Updates

Last Update Posted (Estimate)

September 9, 2016

Last Update Submitted That Met QC Criteria

September 7, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Organ Prolapse

Subscribe